Poland - Pharmaceutical products

Description

The full name of the contract, which, due to the limited number of characters, did not fit in section II.1.1) of the notice, is: Successive supply of medicinal products containing in their composition the active substances prednisone (Encorton 5 mg; Encorton 10 mg; Encorton 20 mg) and sulfamethoxazole + trimethoprim (Biseptol 120 mg; Biseptol 480 mg) for the implementation of a non-commercial clinical trial.
1) Part/Package No. 1 - Medicinal products containing the active substance prednisone (Encorton 5 mg, Encorton 10 mg, Encorton 20 mg) tablets, according to the characteristics of the medicinal product: a) prednisone (Encorton ) 5 mg - 200 op. x 20 tabl. b) prednisone (Encorton ) 10 mg - 200 op. x 20 tabl. c) prednisone (Encorton ) 20 mg - 200 op. x 20 tabl. 1) Part/Package No. 2 - Medicinal products containing the active substance sulfamethoxazole + trimethoprim (Biseptol 120 mg; Biseptol 480 mg) tabl.: a) sulfamethoxazole + trimethoprim (Biseptol 120 mg) - 750 op. x 20 tabl. b) sulfamethoxazole + trimethoprim (Biseptol 480 mg) - 260 op. x 20 tabl.

Opportunity closing date

20 November 2023

Value of contract

to be confirmed